Teenagers who owned promotional items for nicotine-containing products were twice as likely as other teens to start using the products.
New Stanford research suggests a method of analyzing cell-phone videos of children could alleviate the bottleneck in autism diagnosis around the world.
Using a lab model, Stanford researchers identified a type of developing brain cell that is profoundly changed by exposure to low oxygen levels.
Giving an inhaled hormone to children with autism for four weeks improves their social behavior, a new study by Stanford researchers indicates.
Women scheduled for C-sections know the levels of pain relief they'll need, and are happier with their experience if given a choice.
Some viruses help drug-resistant bacteria grow in the lungs of cystic fibrosis patients, new Stanford research shows.
Experts came to Stanford for the Pediatric Innovation Showcase to learn about many approaches to helping children's health, from social media to surgery.
Infectious disease expert Desiree LaBeaud is mapping outbreaks of Zika, dengue and chikungunya, three viral diseases transmitted by the same mosquitoes.
Stanford biomedical data scientist Dennis Wall and his team are developing technology that could help experts study and treat autism simultaneously.
Pediatricians can improve the risk-benefit profile of many common interventions by scaling back what they do, according to a new review article.
For babies in developing countries, pneumonia vaccines seem to work better if their mothers receive treatment for parasitic infections during pregnancy.
In most babies and kids, the sound of their mother's voice gets special treatment in the brain. But in autism, this distinctive brain response is lessened.
A baby born with a rare heart complication is now thriving following two surgeries at Lucile Packard Children's Hospital Stanford.
Nurse-scientist Kimberly Pyke-Grimm draws on her clinical experience when studying how teens, young adults and families make decisions about cancer care.
Type 1 diabetes starts out as a sneak attack by bad-actor antibodies. But scientists at Stanford and UCSF have developed an early-warning system.
More than 50,000 pregnant women per year experience life-threatening complications of pregnancy and childbirth, but no one understands why.
